Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

All experiments were performed in triplicate. The pLenti-CRISPR-V2 vector was used for CRISPR/Cas9-mediated gene knockout in CAL27 and FaDu cell lines. Briefly, lentivirus vector expressing CASP3 gRNA ...

We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector ...

In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the ... All sections were mounted using the Vectashield antifade mounting medium containing DAPI ...

The agreement grants Jumpcode access to ERS' CRISPR/Cas9 patent portfolio, empowering the company to advance the sensitivity and efficiency of next-generation sequencing (NGS) and expand ...

Built around one of the most prolific academic viral vector manufacturing teams ... Focused initially on manufacturing lentivirus and gamma-retrovirus vectors, ViroCell enables clients to start ...

Department of Molecular and Environmental Biotechnology, Faculty of Biology and Biotechnology, University of Science, Ho Chi Minh City 700000, Vietnam Vietnam National University, Ho Chi Minh City ...

aRheumatology Department, Strasbourg University Hospital, Centre de référence pour les maladies auto-immunes systémiques Est – Sud Ouest (RESO), Strasbourg, France bDepartment of Physiology, Muscle ...

most notably with the Broad Institute around intellectual property rights of the CRISPR-Cas9 gene-editing technology. The legal disputes around the patents have created a complex landscape but ...